|Articles|April 12, 2023
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Author(s)Catalent
For studies involving products such as biologics and biosimilars, maintaining reliability of clinical supply can be challenging. Explore how different cold chain strategies can be leveraged to maintain product integrity in transit and minimize disruptions to clinical supply.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
3
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
4
Women in STEM: Cultivating Scientific Confidence
5